Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Anixa Biosciences, Inc.
www.anixa.comAI Executive Summary
AI-powered analysis of 8-K filing content
Anixa Biosciences held its 2026 annual stockholder meeting on March 10, 2026, where board members were re-elected, executive compensation was approved, and the independent auditor was ratified. This routine annual meeting demonstrates stable governance and continued shareholder engagement with 62.3% of shares represented.
Key Takeaways
Four board members were re-elected: Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr., ensuring leadership continuity
Stockholders approved executive compensation on a non-binding advisory basis, indicating shareholder support for management pay practices
2 more takeaways